ER/PR positive breast cancer

Clinical trials for ER/PR positive breast cancer explained in plain language.

Never miss a new study

Get alerted when new ER/PR positive breast cancer trials appear

Sign up with your email to follow new studies for ER/PR positive breast cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New pill targets rare cancer mutation in early trial

Disease control Recruiting now

This study tests a new drug called rezatapopt (PC14586) in people with advanced solid tumors that have a specific TP53 Y220C mutation. The drug is designed to reactivate the p53 protein, which normally helps stop cancer growth. The trial will also test rezatapopt combined with th…

Matched conditions: ER/PR POSITIVE BREAST CANCER

Phase 1/2 • Sponsor: PMV Pharmaceuticals, Inc • Aim: Disease control

Last updated Sep 17, 2026 00:00 UTC

ER/PR positive breast cancer

Get alerted when new ER/PR positive breast cancer trials appear

New pill targets rare cancer mutation in early trial